Free Shipping on purchases over €100

Revita CBD Acondicionador , 205 ml

Revita CBD Conditioner , 205 ml

Revita CBD Conditioner 205 ml is a personal care product formulated with a combination of natural ingredients and CBD extracts. It is suitable for providing deep conditioning and restoring shine and softness to the hair.

SKU: RE8163780214998
Sold out
Promo FD
27.40
€36.37
Temporarily sold out

Subscribe and we will notify you when it becomes available again.

Pharmaceutical Care

Safe medication sales

Secure shipping

INFO AND TECHNICAL SPECIFICATIONS

Revita CBD Conditioner in 205 ml presentation is a hair care product. It is formulated with a blend of natural ingredients and CBD extracts. It provides deep conditioning and improves hair health.

Hemp seed oil, aloe vera leaf extract and provitamin B5 are some of the key components that help moisturise, strengthen and protect hair against damage and breakage. CBD extract also helps to soothe inflammation and irritation of the scalp, resulting in a healthier, shinier mane.

Key benefits include the following:

  • Hemp seed oil and provitamin B5 are known for their moisturising properties, helping to prevent dryness and strengthen the hair fibre.
  • The blend of natural ingredients helps restore vitality and protect hair against damage and breakage.
  • It provides deep conditioning that helps to smooth and detangle hair, making it easier to style.
  • CBD extract has antioxidant and anti-inflammatory qualities that support the natural protection of the strands and scalp against damage caused by external factors such as sun and pollution.
  • The natural ingredients and CBD extracts work together to provide softness and shine to help improve the appearance and texture of the mane.
Tecnical specifications card

Pharmaceutical advice

You can now consult our team with any questions you may have. We remind you that our chatbot is also available for simpler queries.

Ask us
Newsletter

Don’t miss anything

Stay up to date with the latest advances in health, discounts, and pharmaceutical news.